Overview

Single-centre Study to Investigate Safety and Efficacy of Tri-Solfen in Wound Debridement

Status:
Unknown status
Trial end date:
2019-07-30
Target enrollment:
Participant gender:
Summary
This is a Phase IIa open, randomised, single and parallel group, therapy controlled, single centre study, which has been divided into 3 sequential phases, which are designed to study respectively, (a) the time taken to achieve surface anaesthesia, (b) the extent of post-operative pain relief and (c) the depth and quality of anaesthesia during a leg ulcer surgical debridement procedure
Phase:
Phase 2
Details
Lead Sponsor:
Medical Ethics UK Ltd
Collaborators:
ProTherax Ltd
Welsh Wound Innovation Centre Ltd
Treatments:
Acetaminophen
Bupivacaine
Cetrimonium
Epinephrine
Epinephryl borate
Ibuprofen
Lidocaine
Lidocaine, Prilocaine Drug Combination
Racepinephrine